Related references
Note: Only part of the references are listed.Pharmacokinetics and Pharmacodynamics in HIV Prevention; Current Status and Future Directions: A Summary of the DAIDS and BMGF Sponsored Think Tank on Pharmacokinetics (PK)/Pharmacodynamics (PD) in HIV Prevention
Joseph Romano et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2013)
Systemic and Topical Drugs for the Prevention of HIV Infection: Antiretroviral Pre-exposure Prophylaxis
Jared Baeten et al.
ANNUAL REVIEW OF MEDICINE, VOL 64 (2013)
Assessing the physical-chemical properties and stability of dapivirine-loaded polymeric nanoparticles
Jose das Neves et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Ex Vivo Characterization of Particle Transport in Mucus Secretions Coating Freshly Excised Mucosal Tissues
Laura M. Ensign et al.
MOLECULAR PHARMACEUTICS (2013)
In Vitro and Ex Vivo Evaluation of Polymeric Nanoparticles for Vaginal and Rectal Delivery of the Anti-HIV Drug Dapivirine
Jose das Neves et al.
MOLECULAR PHARMACEUTICS (2013)
MTN-001: Randomized Pharmacokinetic Cross-Over Study Comparing Tenofovir Vaginal Gel and Oral Tablets in Vaginal Tissue and Other Compartments
Craig W. Hendrix et al.
PLOS ONE (2013)
Pharmacokinetics of Tenofovir following Intravaginal and Intrarectal Administration of Tenofovir Gel to Rhesus Macaques
Jeremy Nuttall et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Overview of microbicides for the prevention of human immunodeficiency virus
Salim S. Abdool Karim et al.
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2012)
Formulation, pharmacokinetics and pharmacodynamics of topical microbicides
Jessica L. Adams et al.
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2012)
Animal Models for Microbicide Studies
Ronald S. Veazey et al.
CURRENT HIV RESEARCH (2012)
Development and validation of a HPLC method for the assay of dapivirine in cell-based and tissue permeability experiments
Jose das Neves et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2012)
Durable Protection from Vaginal Simian-Human Immunodeficiency Virus Infection in Macaques by Tenofovir Gel and Its Relationship to Drug Levels in Tissue
Charles Dobard et al.
JOURNAL OF VIROLOGY (2012)
Interactions of Microbicide Nanoparticles with a Simulated Vaginal Fluid
Jose das Neves et al.
MOLECULAR PHARMACEUTICS (2012)
Pharmacokinetics and Pharmacodynamics of the Reverse Transcriptase Inhibitor Tenofovir and Prophylactic Efficacy against HIV-1 Infection
Sulav Duwal et al.
PLOS ONE (2012)
Polymeric Nanoparticles Affect the Intracellular Delivery, Antiretroviral Activity and Cytotoxicity of the Microbicide Drug Candidate Dapivirine
Jose das Neves et al.
PHARMACEUTICAL RESEARCH (2012)
Mucus-Penetrating Nanoparticles for Vaginal Drug Delivery Protect Against Herpes Simplex Virus
Laura M. Ensign et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Biodegradable Nanoparticles Composed Entirely of Safe Materials that Rapidly Penetrate Human Mucus
Ming Yang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)
Pre-Exposure Prophylaxis and Antiretroviral Resistance: HIV Prevention at a Cost?
Christopher B. Hurt et al.
CLINICAL INFECTIOUS DISEASES (2011)
Biodegradable Nanoparticles in the Murine Vagina: Trans-Cervical Retrograde Transport and Induction of Proinflammatory Cytokines
Ritu Malik et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2011)
In vivo distribution of surface-modified PLGA nanoparticles following intravaginal delivery
Yen Cu et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women
Salim S. Abdool Karim et al.
LANCET (2011)
A Randomized Trial to Assess Anti-HIV Activity in Female Genital Tract Secretions and Soluble Mucosal Immunity Following Application of 1% Tenofovir Gel
Marla J. Keller et al.
PLOS ONE (2011)
Mucoadhesive nanosystems for vaginal microbicide development: friend or foe?
Jose das Neves et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2011)
Nanotechnology-based systems for the treatment and prevention of HIV/AIDS
Jose das Neves et al.
ADVANCED DRUG DELIVERY REVIEWS (2010)
Pharmacokinetic Assessment of Dapivirine Vaginal Microbicide Gel in Healthy, HIV-Negative Women
Annalene M. Nel et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2010)
Nanoparticle-based vaginal drug delivery systems for HIV prevention
Rama Mallipeddi et al.
EXPERT OPINION ON DRUG DELIVERY (2010)
Pharmacokinetics of 2 Dapivirine Vaginal Microbicide Gels and Their Safety Vs. Hydroxyethyl Cellulose-Based Universal Placebo Gel
Annalene M. Nel et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2010)
Development and validation of a rapid reversed-phase HPLC method for the determination of the non-nucleoside reverse transcriptase inhibitor dapivirine from polymeric nanoparticles
Jose das Neves et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2010)
Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women
Quarraisha Abdool Karim et al.
SCIENCE (2010)
Safety and Availability of Dapivirine (TMC120) Delivered from an Intravaginal Ring
J. Romano et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2009)
Inhibition of Human Immunodeficiency Virus Type 1 Infection by the Candidate Microbicide Dapivirine, a Nonnucleoside Reverse Transcriptase Inhibitor
P. Fletcher et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Effect of carrageenan on poloxamer-based in situ gel for vaginal use: Improved in vitro and in vivo sustained-release properties
Yu Liu et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Safety and Pharmacokinetics of Dapivirine Delivery From Matrix and Reservoir Intravaginal Rings to HIV-Negative Women
Annalene Nel et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
Human Immunodeficiency Virus Type 1 Is Trapped by Acidic but Not by Neutralized Human Cervicovaginal Mucus
Samuel K. Lai et al.
JOURNAL OF VIROLOGY (2009)
Controlled Surface Modification with Poly(ethylene)glycol Enhances Diffusion of PLGA Nanoparticles in Human Cervical Mucus
Yen Cu et al.
MOLECULAR PHARMACEUTICS (2009)
Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA
Kim A. Woodrow et al.
NATURE MATERIALS (2009)
Targeted Delivery of PSC-RANTES for HIV-1 Prevention using Biodegradable Nanoparticles
Anthony S. Ham et al.
PHARMACEUTICAL RESEARCH (2009)
Effects of menstrual cycle on gene transfection through mouse vagina for DNA vaccine
T. Kanazawa et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Setting the stage: host invasion by HIV
Florian Hladik et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Concentrations of dapivirine in the rhesus macaque and rabbit following once daily intravaginal administration of a gel formulation of [14C]dapivirine for 7 days
Jeremy P. Nuttall et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Delivery of microbicides to the vagina: difficulties reported with the use of three devices, adherence to use and preferences
Ellen Hardy et al.
CONTRACEPTION (2007)
Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus
Samuel K. Lai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Intracellular delivery of saquinavir in biodegradable polymeric nanoparticles for HIV/AIDS
Lipa K. Shah et al.
PHARMACEUTICAL RESEARCH (2006)
Mouse model of cervicovaginal toxicity and inflammation for preclinical evaluation of topical vaginal microbicides
BJ Catalone et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Inhibition of vaginal transmission of HIV-1 in hu-SCID mice by the non-nucleoside reverse transcriptase inhibitor TMC120 in a gel formulation
S Di Fabio et al.
AIDS (2003)
Share Paper
